# Donor White Blood Cell Infusion in Treating Patients With Metastatic or Unresectable Cancer

> **NCT00607802** · NA · WITHDRAWN · sponsor: **Wake Forest University Health Sciences**

## Conditions studied

- Unspecified Adult Solid Tumor, Protocol Specific
- Unspecified Childhood Solid Tumor, Protocol Specific

## Interventions

- **BIOLOGICAL:** leukocyte therapy
- **GENETIC:** polymerase chain reaction

## Key facts

- **NCT ID:** NCT00607802
- **Lead sponsor:** Wake Forest University Health Sciences
- **Sponsor class:** OTHER
- **Phase:** NA
- **Study type:** INTERVENTIONAL
- **Status:** WITHDRAWN
- **Start date:** —
- **Primary completion:** —
- **Final completion:** —
- **Target enrollment:** 0 (ACTUAL)
- **Last updated:** 2017-01-19

## Collaborators

- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT00607802

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT00607802, "Donor White Blood Cell Infusion in Treating Patients With Metastatic or Unresectable Cancer". Retrieved via AI Analytics 2026-06-02 from https://api.ai-analytics.org/clinical/NCT00607802. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*